High Risk Cancer

Oncology
0
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Median Technologies
Median TechnologiesChina - Shanghai
2 programs
Median LCSN/A1 trial
Median LCSN/A1 trial
Active Trials
NCT06576232Completed1,147Est. Aug 2024
NCT06751576Completed480Est. Mar 2025

Trial Timeline

Clinical trial activity over time

2022
2023
2024
2025
2026
Median TechnologiesMedian LCS
Median TechnologiesMedian LCS

Clinical Trials (2)

Total enrollment: 1,627 patients across 2 trials

Standalone Observational Study Assessing the Performance of an AI/ML Tech-based SaMD on Chest LDCT Images (REALITY)

Start: Sep 2022Est. completion: Aug 20241,147 patients
N/ACompleted

Retrospective Clinical Trial Comparing Radiologists' Diagnosis Accuracy in Lung Cancer Screening Population With and Without the Help of an AI/ML Tech-based SaMD

Start: Sep 2022Est. completion: Mar 2025480 patients
N/ACompleted

Related Jobs in Oncology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space